Moreover, the percentage of gynecologists who administer more than 3 cycles of neoadjuvant CHT shows a decreasing trend among physicians with a longer experience in gynecologic oncology and correlation between experience in gynecologic oncology and number of neoadjuvant CHT cycles became statistically significant (p=0.017) comparing specialist who administer ≤ 4 cycles with specialist administering > 4 cycles. 110/192 (57.3%) specialists declared to operate as first surgeon (FS) and 82/192 (42.7%) as assistant (AS) ( Supplementary Table 2 ).
← all excerpts
An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.
1
—
—